@metabolon
Metabolon deciphers thousands of discrete chemical signals from genetic and non-genetic factors to reveal biological pathways. We make connections where other omics cannot, and provide the definitive representation of the phenotype. www.metabolon.com
How can metabolomics move beyond traditional biomarkers to better understand human health?
Our Head of R&D, Dr. Annie Evans, explains: mtbln.co/y5rly8
Leadership shaped by diverse perspectives drives scientific progress. Supporting women in science matters.
#InternationalWomensDay
In a new interview, Dr. Heino Heyman, shares how metabolomics helped uncover metabolic signatures linked to neurological events in patients treated with CAR-T therapies. ๐ lnkd.in/ezrSdvXr
Do you want to implement metabolomics in your drug development workflows? Watch: mtbln.co/3gavtd
What if inflammatory cytokines arenโt the best predictors of CAR-T neurotoxicity?
Across 3,800+ samples from six trials, metabolomics revealed pathway-level disruptions that outperformed IL-6 and TNFฮฑ in predicting severe events. Disease progression shared metabolic drivers.
More: mtbln.co/azc4kw
On #InternationalWomenAndGirlsInScienceDay, we celebrate the incredible women scientists at Metabolon.
Special congratulations to Dr. Annie Evans and Dr. Natasa Giallourou, featured by @metabolomicsj.bsky.social for their outstanding contributions to the field.
Proud to work alongside you. ๐งช๐
Read more about this announcement in the press release: mtbln.co/d3kucj
A new metabolite has joined the team!
Help us welcome Andrew Messick, our new Chief Financial Officer.
Drew brings more than 25 years of financial leadership experience in the life sciences and will be instrumental as we continue to scale and advance our strategic growth initiatives.
Contact us today to learn more: mtbln.co/nzzd43
@metabolomicsj.bsky.social
Can dried blood spots (DBS) support scalable, minimally invasive, remote studies?
A new study in @metabolomicsj.bsky.social shows that DBS capture exercise-induced metabolic changes across broad pathway coverage using Metabolon's platform.
Episode 5 is live! Molecules to Medicine โ Dosing & Timing
In this episode, Dr. Natasa Giallourou explores how pharmacometabolomics can refine both dose and timing, using a busulfan/HSCT case study to demonstrate its advantages over traditional PK/PD approaches.
Watch here: mtbln.co/lahkjb
Molecules to Medicine Episode 4 is live! Safety & Toxicity
Safety failures are a major cause of drug attrition. Learn more about a CAR-T case study showing how metabolomics revealed the biochemical drivers of toxicity, helping a safer and more effective use of this therapy. mtbln.co/9bczl8
Molecules to Medicine - Episode 3: Translatability
How well do findings in non-human models translate to humans? Dr. Heino Heyman shows how metabolomics confirms conserved biochemical pathways across multiple Battenโs Disease models, boosting confidence in the next steps.
๐https://mtbln.co/2idajz
New Webinar Series: ๐ Molecules to Medicineโ๏ธ
Learn how metabolomics drives decisions across the drug development pipeline, from target ID to safety, dosing & patient stratification.
๐บ Watch Ep1 on how metabolomics was applied to identify candidate drug targets for (IBD): mtbln.co/sfqmwo
How do lifelong environmental exposures shape health?
Our eBook, Guide to the Exposome, explores how metabolomics is unlocking this complexity, advancing research, public health, and precision medicine.
Download your copy: mtbln.co/xeokxe
Continuous improvement drives us at Metabolon.
Our recent Kaizen workshop transformed the quoting process, modernizing workflows, boosting accuracy, and accelerating customer experience. A culture of excellence, built for scale.
Read more about our recent Kaizen workshop:
Pharma companies take note - human knockouts in bottleneck and consanguineous populations are up and coming.
Plasma Metabolic Outliers Identified in #Estonian Human Knockouts: www.mdpi.com/2218-1989/15...
citing our #Qatar study with @metabolon.bsky.social data:
www.cell.com/cell-genomic...
Unlock functional biology with metabolomics!
Join our webinar to see how integrating metabolomics into multiomics reveals hidden pathways & drives biological insight.
Discover DIABLO & PathIntegrate in action through real case studies.
Register today!
buff.ly/AtD7tti
From data to destiny: reproducible #metabolomics is the foundation of a connected multiomics future.
When metabolomics meets genomics, proteomics & transcriptomics, discovery moves from possibility to proof.
Read more in our latest blog:
Metabolomics isnโt just transforming human health; itโs helping our pets live healthier, longer lives.
A new study from The Farmerโs Dog, supported by Metabolon, shows how fresh, human-grade diets drive metabolic changes linked to healthy aging.
Learn more: buff.ly/FcAokL4
Metabolon at #ELRIGDrugDiscovery2025!
Don't miss our poster "Integrative Multiomics: Bridging Metabolomics & Proteomics for Systems-Level Insights".
Discover how Metabolonโs platform helps translate complex data into actionable insights for drug discovery!
#DD25
At #ASHG25?
We are too!
Come by booth #1160 to know more about how the combination of genomics with metabolomics can transform raw data into precise biomarkers and biological insights.
Metabolon has now been cited in 4,000+ peer-reviewed publicationsโmore than any other provider in the industry.
Itโs more than a number: it shows the trust scientists have in our work and the critical role of metabolomics in multi-omics research.
Hereโs to the next 4k citations!
Most dietary biomarker research focuses on Western populations, but diet & metabolism differ across cultures.
A new Nature Metabolism study from Singaporeโs HELIOS cohort shows how multi-biomarker panels link diet to health in diverse Asian groups.
Watch the webinar to learn more! mtbln.co/6c0u0n
Zoltan, Virginie, and Joey are at EMBL: The Human Microbiome Symposium this week.
Visit us to explore how combining metagenomics with metabolomics provides a complete picture of the microbiomeโs role in human health.
Not at the Symposium? Contact us to know more!
๐ข Press Release:
Metabolon partners with China Kadoorie Biobank (CKB), one of the world's largest and most comprehensive cohort studies, to better understand how genetics, environment, lifestyle, and socioeconomic factors shape chronic diseases in underrepresented populations.
#PrecisionMedicine
Watch Dr. Lasky-Su during her recent webinar as she shares findings establishing the metabolome as a powerful bridge between aging, the exposome, and clinical outcomes in both aging and disease.
https://www.metabolon.com/resources/videos/multiomic-integration-metabolome-biological-aging-precision-medicine-in-autism-asthma/
Metabolon extends heartfelt congratulations to Dr. Jessica Lasky-Su on her well-deserved recognition as an Honorary Fellow of the Metabolomics Society. Dr. Lasky-Su has been a pioneering force in the field, advancing our understanding of how metabolic perturbations influence human health outcomes.
Metabolon is attending #ASMS2025!
And you?
If so, visit poster #560 on Tuesday, where Richard Robinson will present: โBuilding Biologically Relevant Libraries: How Comprehensive Libraries and Deep MS/MS Coverage Enable Intelligent Library Growth.โ
#MassSpectrometry"
Unlock the Secrets of the Microbiome!
Join us for our webinar this week with Metabolonโs microbiome experts as we explore how metabolomics is reshaping microbiome research.
Metabolon is proud to join @exposomemoonshot.bsky.social to explore how environmental exposure shapes health. By decoding the exposome, #exposomicsย can link exposure to environmental illness, drive innovation, and enable chronic disease preventionย while shapingย public health policies.
